The Role of Radiotherapy in the Treatment of Small-Cell Lung Cancer

por Nosaki, Kaname, Seto, Takashi
Publicado 2015

Insights into brain metastasis in patients with ALK+ lung cancer: is the brain truly a sanctuary?

por Toyokawa, Gouji, Seto, Takashi, Takenoyama, Mitsuhiro, Ichinose, Yukito
Publicado 2015

Spotlight on lorlatinib and its potential in the treatment of NSCLC: the evidence to date

por Akamine, Takaki, Toyokawa, Gouji, Tagawa, Tetsuzo, Seto, Takashi
Publicado 2018

Optimizing Sequential Treatment With EGFR Tyrosine Kinase Inhibitor With a Simulation of the T790M Mutation Rate in EGFR–Mutated Lung Cancer

por Haratake, Naoki, Misumi, Toshihiro, Yamanaka, Takeharu, Seto, Takashi
Publicado 2020

Plerixafor stem cell mobilization in Japanese children: A post‐marketing study

por Goto, Hiroaki, Kanamori, Rie, Nishina, Satoshi, Seto, Takashi
Publicado 2022

Clinicopathological features of younger (aged ≤ 50 years) lung adenocarcinoma patients harboring the EML4‐ALK fusion gene

por Kometani, Takuro, Sugio, Kenji, Osoegawa, Atsushi, Seto, Takashi, Ichinose, Yukito
Publicado 2018

Rapidly Destructive Coxarthrosis as a Potential Side Effect of Crizotinib in a Patient with ROS1-Positive Lung Adenocarcinoma

por Takamori, Shinkichi, Seto, Takashi, Jinnouchi, Mikako, Oba, Taro, Yamaguchi, Masafumi, Takenoyama, Mitsuhiro
Publicado 2020

Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance Study

por Tsukada, Nobuhiro, Nishikori, Momoko, Goto, Hiroaki, Kanamori, Rie, Nishina, Satoshi, Seto, Takashi, Iida, Shinsuke
Publicado 2021

Real-World EGFR T790M Testing in Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study in Japan

por Seto, Takashi, Nogami, Naoyuki, Yamamoto, Nobuyuki, Atagi, Shinji, Tashiro, Naoki, Yoshimura, Yoko, Yabuki, Yutaka, Saka, Hideo
Publicado 2018

Dramatic intracranial response to tepotinib in a patient with lung adenocarcinoma harboring MET exon 14 skipping mutation

por Takamori, Shinkichi, Matsubara, Taichi, Fujishita, Takatoshi, Ito, Kensaku, Toyozawa, Ryo, Seto, Takashi, Yamaguchi, Masafumi, Okamoto, Tatsuro
Publicado 2021

Anti–PD-1 Monotherapy for Advanced NSCLC Patients with Older Age or Those with Poor Performance Status

por Matsubara, Taichi, Seto, Takashi, Takamori, Shinkichi, Fujishita, Takatoshi, Toyozawa, Ryo, Ito, Kensaku, Yamaguchi, Masafumi, Okamoto, Tatsuro
Publicado 2021

Successful treatment of locally advanced lung cancer using late concurrent chemoradiation therapy administered after immune checkpoint inhibitor plus platinum chemotherapy

por Matsubara, Taichi, Takamori, Shinkichi, Fujishita, Takatoshi, Toyozawa, Ryo, Ito, Kensaku, Yamaguchi, Masafumi, Seto, Takashi, Okamoto, Tatsuro
Publicado 2021

Concurrent chemoradiotherapy with cisplatin + S-1 versus cisplatin + other third-generation agents for locally advanced non-small-cell lung cancer: a meta-analysis of individual pa...

por Taniguchi, Yuri, Okamoto, Hiroaki, Shimokawa, Tsuneo, Sasaki, Tomonari, Seto, Takashi, Niho, Seiji, Ohe, Yuichiro, Saigusa, Yusuke
Publicado 2022

The impact of immune-inflammation-nutritional parameters on the prognosis of non-small cell lung cancer patients treated with atezolizumab

por Matsubara, Taichi, Takamori, Shinkichi, Haratake, Naoki, Toyozawa, Ryo, Miura, Naoko, Shimokawa, Mototsugu, Yamaguchi, Masafumi, Seto, Takashi, Takenoyama, Mitsuhiro
Publicado 2020

Histological conversion from adenocarcinoma to small cell carcinoma of the lung after treatment with an immune checkpoint inhibitor: a case report

por Miura, Naoko, Matsubara, Taichi, Takamori, Shinkichi, Haratake, Naoki, Toyozawa, Ryo, Yamaguchi, Masafumi, Seto, Takashi, Taguchi, Kenichi, Takenoyama, Mitsuhiro
Publicado 2020

Brain cavernous hemangioma mimicking radiation‐induced necrosis in a patient with non‐small cell lung cancer

por Takamori, Shinkichi, Seto, Takashi, Jinnouchi, Mikako, Matsubara, Taichi, Haratake, Naoki, Miura, Naoko, Toyozawa, Ryo, Yamaguchi, Masafumi, Takenoyama, Mitsuhiro
Publicado 2020

Cohesion between pulmonary artery and bronchus after immune checkpoint inhibitor therapy in a lung cancer patient

por Takamori, Shinkichi, Takenoyama, Mitsuhiro, Matsubara, Taichi, Fujishita, Takatoshi, Ito, Kensaku, Yamaguchi, Masafumi, Toyozawa, Ryo, Seto, Takashi, Okamoto, Tatsuro
Publicado 2020

Lorlatinib-Induced Pulmonary Embolism in a Patient With an ALK-Positive NSCLC

por Toyozawa, Ryo, Haratake, Naoki, Toyokawa, Gouji, Matsubara, Taichi, Takamori, Shinkichi, Miura, Naoko, Yamaguchi, Masafumi, Takenoyama, Mitsuhiro, Seto, Takashi
Publicado 2020

Atezolizumab-Induced Aseptic Meningitis in Patients with NSCLC

por Toyozawa, Ryo, Haratake, Naoki, Toyokawa, Gouji, Matsubara, Taichi, Takamori, Shinkichi, Miura, Naoko, Yamaguchi, Masafumi, Takenoyama, Mitsuhiro, Seto, Takashi
Publicado 2020

Erlotinib with or without bevacizumab as a first‐line therapy for patients with advanced nonsquamous epidermal growth factor receptor‐positive non‐small cell lung cancer: Explorato...

por Hosomi, Yukio, Seto, Takashi, Nishio, Makoto, Goto, Koichi, Yamamoto, Noboru, Okamoto, Isamu, Tajima, Kosei, Kajihara, Yusuke, Yamamoto, Nobuyuki
Publicado 2022